Hydroxyapatite is a naturally occurring mineral form of calcium apatite, with the chemical formula Ca5(PO4)3(OH). It is the major mineral component of dental enamel, bones, and marine exoskeletons. Hydroxyapatite possesses excellent biocompatibility and bioactive properties that supports bone ingrowth. It is widely used in medical implants and dental care products such as root canal filling materials, bone cements, dental fillings, and orthopedic coatings. Steady rise in geriatric population coupled with increasing incidence of oral diseases and dental complications has augmented the demand for dental restoration and periodontal therapies. Hydroxyapatite-based dental fillings and root canal sealing materials offer superior bonding strength and biocompatibility compared to other alternatives.
The global hydroxyapatite market is estimated to be valued at US$ 2,396.9 Mn in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
The hydroxyapatite market is expected to experience significant growth over the forecast period. Rising prevalence of dental complications such as cavities, periodontitis, dental fractures etc. due to factors such as changing lifestyle, poor dietary habits and growing consumption of sugar-rich food and drinks is expected to boost the demand for dental restoration materials including hydroxyapatite. According to the statistics provided by the World Health Organization in 2020, oral diseases affect nearly 3.5 billion people worldwide with dental caries (cavities) being the most common oral disease. Advancements in biomaterial sciences has enabled development of technologically advanced hydroxyapatite scaffolds and composites with improved mechanical properties and osteoconductive ability. This has broadened the application scope of hydroxyapatite in orthopedic and maxillofacial reconstruction procedures. Implementation of favorable government initiatives to increase accessibility to dental care services in low and middle-income countries is also projected to propel the market growth over the forecast period.
Segment Analysis
The hydroxyapatite market is segmented into synthetic and natural. The synthetic segment dominates the market and accounts for around 80% of the market share. This is because synthetic hydroxyapatite offers better consistency and quality compared to natural hydroxyapatite. Within synthetic, biomimetic crystalline-phase synthetic hydroxyapatite is the fastest growing segment due to its natural bone-like structure.
PEST Analysis
Political: The hydroxyapatite market is positively impacted by increasing healthcare expenditures and investments by various governments across the globe.
Economic: The market is expected to grow owing to rising disposable incomes, growing medical tourism industry and increasing prevalence of bone-related disorders.
Social: Changing lifestyles, increasing health consciousness and rising patient pool for age-related bone disorders are driving the market growth.
Technological: Advancements in coating and particle size optimization techniques are helping manufacturers develop innovative hydroxyapatite formulations with improved potency and stability. 3D printing technology is also being explored for developing customized hydroxyapatite bone grafts.
Key Takeaways
The Global Hydroxyapatite Market Size is expected to witness high growth over the forecast period of 2023 to 2030.
Regional Analysis: The North American region currently dominates the market owing to presence of major players and growing dental & orthopedic procedures. The Asia Pacific region is expected to be the fastest growing market with countries like China and India emerging as lucrative markets.
Key players operating in the hydroxyapatite market are West Pharmaceutical Services Inc., Berry Global Inc., Sartorius AG, Corning Inc., Gerresheimer AG, SCHOTT AG, Stevanato Group. These players are focusing on new product launches, partnerships and capacity expansions to strengthen their market position. For instance, West Pharmaceutical Services Inc. launched EnviroThane FluoroSeal fluoropolymer coating for prefilled syringes to provide puncture and break resistance.